Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

Vermont Senator Peter Welch is among lawmakers urging the Trump administration not to roll back efforts that make medications ...

Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Medicare announced plans to negotiate lower prices for 15 costly drugs, including Ozempic, Wegovy, and Trelegy Ellipta, ...